American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Donate
Your AHNS Member Panel

Andrew Larson – Burlington, Massachusetts

Published on by Andrew Larson

Practice Contact Information

Lahey Hospital And Medical Center/Boston University
41 Burlington Mall Road

Burlington
Massachusetts
01805
United States

Phone: 781.744.8450
Email: [email protected]
Web Site: https://physicians.lahey.org/details/4420/andrew-larson-otolaryngology_ear_nose__throat-burlington

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Dr. Larson is a Head and Neck Oncologic/Reconstructive Surgeon at Lahey Hospital and Medical Center in Burlington, MA, and has an academic appointment as Assistant Professor at Boston University School of Medicine.  He received his medical degree from the University of California, San Francisco, and also completed residency training in Otolaryngology-Head and Neck Surgery at the University of California, San Francisco.  He completed a fellowship in Head and Neck Oncologic, Skull Base, and Microvascular Reconstructive Surgery at Massachusetts Eye and Ear in Boston, MA.  Dr. Larson has extensive training in transoral robotic surgery, microvascular head and neck reconstruction, thyroid and parathyroid surgery, and surgeon-person ultrasound.

Clinical Trials

Bibliography

  1. Larson AR, Ryan WR. Transoral Excision of Parapharyngeal Space Tumors. Otolaryngol Clin North Am. 2021 June; doi:10.1016/j.otc.2021.03.001. PMID: 34024481.
  2. Larson AR, Kong KA, Walvekar RR, Ryan WR. Obstructive Sialadenitis: Stones and Stenosis.  Curr Otorhinolaryngol Rep. Published online 2021:1-8. doi:10.1007/s40136-021-00339-5.
  3. Larson AR, Han M, Webb KL, et al. Patient-Reported Outcomes of Split-Thickness Skin Grafts for Floor of Mouth Cancer Reconstruction. ORL. Published online 2021:1-8. doi:10.1159/000512085. PMID: 33582667.
  4. Stanford-Moore GB, Ochoa E, Larson AR, Han M, Hoppe K, Ryan WR. Patterns of Nodal Metastases and Predictors of Occult Disease in HPV-Associated Oropharynx Cancer. Otolaryngol Head Neck Surg. 2020 Sept; doi: 10.1177/0194599820951473.
  5. Ochoa E, Larson AR, Han M, Webb KL, Stanford-Moore G, El-Sayed IH, George JR, Ha PK, Heaton CM, Ryan WR. Patient-reported Quality of Life After Resection with Primary Closure for Oral Tongue Carcinoma.   2020 May 7; doi: 10.1002/lary.28723. PMID: 32379355.
  6. Formeister EJ, Baum R, Knott PD, Seth R, Ha P, Ryan W, El-Sayed I, George J, Larson AR, Plonowska K, Heaton C. Machine Learning for Predicting Complications in Head and Neck Microvascular Free Tissue Transfer. Laryngoscope. 2020 Jan 28. PMID: 31990084.
  7. Han M, Stanford-Moore GB, Larson AR, Schoppy DW, Cognetti DM, Joshi AS, Houlton JJ, Ryan WR. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone. Laryngoscope. 2019 Nov 1;. doi: 10.1002/lary.28344.  PMID: 31675132.
  8. Larson AR, Kemmer J, Formeister E, El-Sayed I, Ha P, George J, Ryan W, Chan E, Heaton C. Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma. Laryngoscope. 2019 Aug 14;doi: 10.1002/lary.28241. PMID: 31411752.
  9. Larson AR, Aubin-Pouliot A, Delagnes E, Zheng M, Chang JL, Ryan WR. Surgeon-Performed Ultrasound for Chronic Obstructive Sialadenitis Helps Predict Sialendoscopic Findings and Outcomes. Otolaryngol Head Neck Surg. 2017 Dec;157(6):973-980. PMID: 28871894.
  10. Niethamer TK, Larson AR, O’Neill AK, Bershteyn M, Hsiao EC, Klein OD, Pomerantz JH, Bush JO. EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells. Stem Cell Reports. 2017 Feb 22. PMID: 28238796.
  11. O’Neill AK, Kindberg AA, Niethamer TK, Larson A, Ho HH, Greenberg ME, Bush JO. Unidirectional Eph/ephrin signaling creates a cortical actomyosin differential to drive cell segregation. J Cell Biol. 2016 Oct 24; 215(2):217-229. PMID: 27810913.
  12. Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ, Barani IJ, James CD, Parsa AT. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol. 2014 May; 16(5):628-36. PMID: 24696499; PMCID: PMC3984561.